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Abstract 
I n   s i t u  neoplastic prostate cells a r e   n o t   l e t h a l   u n l e s s   t h e y   b e c o m e   i n v a s i v e   a n d   m e t a s t a t i c .   F o r  
cells  to  become  invasive,  the prostate gland must undergo degradation of the basement 
membrane and disruption of the basal cell layer underneath the luminal epithelia. Although the 
roles of proteinases in breaking down the basement membrane have been well-studied, little 
is known about the factors that induce basal cell layer disruption, degeneration, and  its 
eventual disappearance in invasive cancer. It is hypothesized that microenvironmental factors 
may affect the degradation of the basal cell layer, which if protected may prevent tumor 
progression and invasion. In this study, we have revealed differential  protein  expression 
patterns between epithelial and stromal cells isolated from different prostate pathologies and 
identified several important epithelial and stromal proteins that may contribute to inflam-
mation and malignant transformation of human benign prostate tissues to cancerous tissues 
using matrix-assisted laser desorption ionization time-of-flight mass spectrometry and pro-
teomics methods. Cellular retinoic acid-binding protein 2 was downregulated in basal cells of 
benign prostate. Caspase-1   a n d interleukin-18 receptor 1 were highly expressed in leukocytes 
of prostate cancer. Proto-oncogene Wnt-3 was downregulated in endothelial cells of pros-
tatitis tissue and tyrosine phosphatase non receptor type 1 was only found in normal and 
benign endothelial cells. Poly ADP-ribose polymerase 14 was downregulated in myofibrob-
lasts of prostatitis tissue. Interestingly, integrin alpha-6 was upregulated in epithelial cells but 
not detected in myofibroblasts of prostate cancer. Further validation of these proteins may 
generate new strategies for the prevention of basal cell layer disruption and subsequent 
cancer invasion.  
Key words: Prostate cancer, tumor microenvironment, inflammation, tumorigenesis, protein bio-
markers, magnetic bead cell separation 
Introduction 
P r o s t a t e   c a n c e r   i s   t h e   m o s t   c o m m o n   n o n -skin 
m a l i g n a n c y   i n   m e n   a n d   t h e   s e c o n d   l e a d i n g   c a u s e   o f  
cancer-death  in  the  United  States.  It  develops  in  a 
s e r i e s   o f   m o r p h o l o g i c   a n d   g e n e t i c   s t e p s   t h a t   b e g i n s  
with  the  transformation  of  normal  tissue  to  hyper-
plastic lesions, and continues to high-grade prostatic Journal of Cancer 2010, 1 
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intraepithelial neoplasia (HGPIN), invasion and me-
tastasis.  
In addition to neoplastic epithelial cells, tumors 
also  contain  a  highly  complex  microenvironment 
composed of a mixture of fibroblasts, myofibroblasts, 
endothelial cells, inflammatory cells and extracellular 
matrix. As tumor progresses, carcinoma cells prolife-
rate and invade the surrounding stroma through the 
basement membrane. As a response to the disruption 
of normal tissue homeostasis, the stroma wil l   u n d e r g o  
s e v e r a l   m o d i f i c a t i o n s   c r e a t i n g   n e w   s t r o m a l   m i c r o e n-
vironment  termed  ‘reactive’  stroma  which  differs 
f r o m   t h e   s t r o m a   i n   n o r m a l   t i s s u e   a n d   c a n   p r o m o t e  
tumorigenesis 1. These modifications include prolife-
ration  of  fibroblasts  2,  lymphocyte  infiltration  3, 
extracellular matrix remodeling and increased angi-
ogenesis 1. 
Transformed carcinoma cells which result from 
accumulation of gene t i c   m u t a t i o n s   h a v e   b e e n   t h e   f o-
c u s   o f   c a n c e r   r e s e a r c h   f o r   m a n y   y e a r s   a n d   t h e y   w e r e  
c l a i m e d   t o   b e   t h e   t r i g g e r   o f   m a l i g n a n t   p h e n o t y p e .  
However,  this  epithelial  cell-driven  tumorigenesis 
viewed the surrounding stroma as a passive support 
structure and neglected its contribution in the malig-
nant  transformation.  Historically,  Paget  recognized 
the importance of tumor microenvironment in cancer 
progression and proposed the “seed and soil” hypo-
thesis in 1889  4.   I n   t h i s   h y p o t h e s i s ,   P a g e t   p o i n t e d   o ut 
the importance of the interaction between tumor cells 
and  microenvironment  in  oncogenesis  and  cancer 
progression. Recent studies provided insight into this 
crosstalk and identified key role of stromal cells in 
m a n y   s t e p s   o f   t u m o r   d e v e l o p m e n t   a n d   i n v a s i o n  5,6. It 
is now understood that microenvironmental interac-
tions in carcinomas are crucial in cancer progression. 
Carcinoma  associated  fibroblasts  (CAFs)  enhanced 
tumor  progression  and  transformation  of  nontumo-
rigenic,  immortalized  human  prostatic  cell  line  2. 
A n o t h e r   p r i n c i p a l   c o m p o n e n t   o f   r e a c t i v e   s t r o m a   i s  
tumor associated macrophages. A localized increase 
of leukocyte infiltration was observed in malignant 
prostate tissue as compared to adjacent benign areas 
3,7,8.   A   g l o b a l   e x p r e s s i o n   a n a l y s i s   o f   r e a c tive stroma in 
prostate  cancer  shows  differential  gene  expression 
p a t t e r n   i n   t u m o r   a s s o c i a t e d   s t r o m a   v e r s u s   n o r m a l  
stroma  9,10. Taken together, these studies underscore 
the stromal-epithelial interface as a critical mediator 
of oncogenic potential. While stromal cells are influ-
enced by the adjacent epithelium via paracrine me-
c h a n i s m s ,   t h e y   a r e   n o t   j u s t   r e s p o n d i n g   t o   t h e s e   s t i m u l i  
but also actively affecting the fate of adjacent epithe-
lium. These data demonstrate that targeting the tumor 
microenvironment  can  be  a  feasible  therapeutic 
strategy. 
Almost  all  current  cancer  therapies  target  the 
tumor epithelial cells from which prostate carcinomas 
a r e   t h o u g h t   t o   a r i s e .   H o w e v er, the genetic instability 
o f   e p i t h e l i a l   c e l l s   c a u s e d   t h e m   t o   a c q u i r e   r e s i s t a n c e   t o  
most therapies. Now, extensive efforts are dedicated 
to explore therapies that target more genetically stable 
s t r o m a l   c e l l s   t h a t   a r e   l e s s   l i k e l y   t o   d e v e l o p   r e s i s t a n c e .  
Therefore,  targeting  tumor  microenvironment  in  an 
attempt  to  identify  novel  stromal  biomarkers  may 
provide a promising opportunity for prostate cancer 
prevention  and  treatment.  Toward  that  end,  the 
present  study  focuses  on  proteomic  analysis  of 
stromal cells and  epithelial  cells  in  normal,  benign, 
cancerous and inflammatory prostate tissues. Differ-
ent  cell  types  including  leukocytes,  myofibroblasts, 
endothelial cells, basal cells and epithelial cells are 
isolated and profiled. The identification of some mo-
lecul a r   m a r k e r s   m a y   h e l p   t o   u n d e r s t a n d   t h e   m o l e c u-
lar mechanisms that govern the initiation of invasion.  
Materials and Methods 
Tissue preparation 
Fresh  frozen  prostate  tumor  specimens  were 
collected from our collaborator Dr. Kenneth Iczkows-
ki.  The  pathologies  of  the  prostate  tissues  used  are 
normal, benign prostatic hyperplasia (BPH),  prostati-
t i s ,   a n d   p r o s t a t e   c a n c e r .   C o l l e c t i v e l y ,   t h e   t i s s u e s   w e r e  
minced  and  cell  suspension  was  prepared  as  de-
scribed in Allinen et  al.  11.   B r i e f l y ,   t i s s u e s   w e r e   d i-
gested into 1-2 m m   p i e c e s ,   i n c u b a t e d   i n   5   x   v olume of 
DMEM  that  contains  2 mg/mL collagenase I and 2 
mg/mL hyaluronidase at 37  º C   f o r   2   h o u r s .   T u b e s  
w e r e   t h e n   c e n t r i f u g e d   a t   3 0 0 0   x   g   f o r   1 0   m i n u t e s .   T h e  
supernatants  were  discarded.  Pellets  were  washed 
w i t h   1   x   H B S S .   T u b e s   w e r e   t h e n   c e n t r i f u g e d   a t   3 0 0 0   x  
g   f o r   1 0   m i n u t e s .   S upernatant  were  discarded  and 
pellets were collected. Pellets were then incubated in 
1 0   x   v o l u m e   o f   t r y p s i n / E D T A   a t   3 7  ºC  f o r   5   m i n u t e s .  
Ice cold medium including 10% FBS was then added 
to  the  mixture  as  needed  to  filter  the  pellets.  The 
mixture was then filtered through a 100 μm than 40 
μm  a n d   t h e n   a   2 0   μ m  filter  mesh  strainer.  Flow 
t h r o u g h   w a s   t h e n   c e n t r i f u g e d   a t   3 0 0 0   x   g   f o r   5   m i-
nutes. Cell mixture was then collected, washed with 
H B S S ,   c e n t r i f u g e d   a t   3 0 0 0   x   g   f o r   5   m i n u t e s .   C e l l s  
were collected and resuspended in 200 μL/ 1 million 
cells with PBE.  
Cell separation 
Cells were separated according to the diagram in 
Figure 1 using dynal beads. The beads are attached to 
antibodies specific to surface marker of the cells to be 
separated. Following the manufacturer’s instructions, 
1 0 0   μ l   o f   t h e   d y n a l  beads  a r e   a d d e d   t o   t h e   c e l l   s u s-Journal of Cancer 2010, 1 
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p e n s i o n ,   i n c u b a t e d   f o r   2 0   m i n u t e s   a t   4  ºC with gentle 
tilting and rotation and placed on the magnet for 2 
m i n u t e s .   T h e   b e a d   b o u n d   c e l l s   a r e   w a s h e d   3   t i m e s   b y  
resu s p e n d i n g   i n   P B E   b u f f e r   t o   r e m o v e   c o n t a m i n a t i n g  
cells,  and  then  the  captured  cells  are  frozen  imme-
d i a t e l y   o n   d r y   i c e .   U n b o u n d   c e l l s   a r e   c o l l e c t e d   b y  
c e n t r i f u g a t i o n   a n d   r e c o n s t i t u t e d   i n   P B E   b u f f e r .   E p i-
thelial  enrich  dynabeads  (Cat  #  161.02,  Invitrogen, 
Carls b a d ,   C A ) ,   C D 3 1   b e a d s   ( C a t   #  111.55D Invitrogen, 
Carlsbad,  CA),  and  equal  mixture  of  CD45  (Cat  # 
111.53D, Invitrogen, Carlsbad, CA) and CD15 (Cat # 
111.37D, Invitrogen, Carlsbad, CA) beads were used 
to isolate epithelial cells, endothelial cells and leuko-
cytes  respectively.  CELLection  Biotin  Binder  dyna-
beads (Cat # 115.33D, Invitrogen, Carlsbad, CA) were 
incubated  fo r   2   h o u r s   a t   R T   w i t h   C D 4 4   ( C a t   # 
CL89153B, Cedarlane, Burlington, NC) or CD10 bio-
tinylated  antibodies  (Cat  #  13-0108-82,  eBioscience, 
San Diego, CA) to isolate basal cells or myofibroblasts 
respectively. 
 
Figure 1. A schematic diagram/flow chart for the isolation of epithelial cells, basal cells, endothelial cells, leukocytes, and 
other types of cells from normal, benign, cancerous and chronic inflammatory human prostate tissues using magnetic beads 
conjugated to antibodies targeting specific membrane cell markers (Adapted from Allinen et al. 
23). 
 
Protein extraction and quantification 
Cells were  lysed by adding cell lysis buffer (30 
m M   T r i s ,   7   M   U r e a ,   4 %   C H A P S ,   p r o t e a s e   i n h i b i t o r ) ,  
followed by vortexing for 1 hour then centrifugation 
for 15 min at 15000g. The supernatant was used for 
protein quantification. Microplate bicinchoninic acid 
( B C A )   P r o t e i n   a s s a y   k i t   ( P i e r c e ,   R o c kford,  IL)  was 
used  to  determine  the  protein  concentration  using 
bovine  serum  albumin  as  a  standard  according  to 
manufacturer’s instructions. A triplicate of each sam-
ple was utilized and the mean absorbance was used to 
calculate  the  concentration  of  the  protein  using  the 
standard curve. 
Two-dimensional gel electrophoresis 
Two-dimensional  gel  electrophoresis  was  per-
formed as described previously 12. Briefly, a total of 50 
µ g   o f   p r o t e i n s   w e r e   v a c u u m -dried and reconstituted 
i n   2 0 0   µ L  o f   r e h y d r a t i o n   b u f f e r   ( 3 0   m M   T r i s ,   7   M   U r e a ,  
4 %   C H A P S ,   5 0  m M   D T T ) .   I s o e l e c t r i c   f o c u s i n g   w a s   r u n  
as  first  dimension  using  immobilized  pH  gradient 
( I P G )   s t r i p s ,   p H   4   t o   7   ( B i o -R a d ) .   T h i s   was followed by 
rehydration of the strips in two equilibration buffers 
using  2  mL f o r   1 5   m i n   e a c h .   T h e   f i r s t   b u f f e r   c o n s t i-
tuted of 375 mM Tris-HCL pH 8.8, 6 M urea, 2% SDS 
and 2% DTT. The second buffer was composed of 375 
mM  Tris-HCL  pH  8.8,  6  M  urea, 2% SDS and  2% 
iodoacetamide.  Proteins  were  then  separated  using 
Polyacrylamide  Gel  Electrophoresis  (PAGE)  where 
the strips were placed on 10% polyacrylamide gel and 
a l l o w e d   t o   e l e c t r o p h o r e s e   a t   5 0   V   f o r   3 0   m i n   t h e n   a t  
1 0 0   V   t i l l   t h e   e n d   o f   s e p a r a t i o n .   T h e   c a t h o d e   b u f f e r  
u s e d   c o n s i s t e d   o f   0 . 1   M   T r i c i n e ,   0 . 1   M  Tris-HCl pH 
8 . 2 ,   a n d   0 . 1 %   S D S ;   w h e r e a s   t h e   a n o d e   b u f f e r   w a s   0 . 2  
M Tris-HCl pH 8.9. Gels were fixed in 40% ethanol 
and 10% acetic acid and stained with SYPRO Ruby 
(Bio-Rad) for 3 hours at room temperature. Gels were 
destained in 10% methanol and 7% acetic a c i d   t o   d e-Journal of Cancer 2010, 1 
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crease  background  staining  followed  by  washing  3 
times in ddH2O. Typhoon 9410 Scanning Systems (GE 
H e a l t h c a r e )   w a s   u s e d   t o   s c a n   t h e   g e l s .   T h e   e x c i t a t i o n  
wavelength was 457 nm and the signals were detected 
at 550 V. 
Trypsin Digestion and Matrix-assisted Laser 
Desorption Ionization Time-of-flight Mass Spec-
trometry (MALDI-TOF MS) 
Protein  digestion  was  performed  as  described 
previously  13.  B r i e f l y ,   p r o t e i n   s p o t s   f r o m   2 D E   g e l s  
w e r e   e x c i s e d   u n d e r   U V   l i g h t ,   c o m b i n e d ,   a n d   i n c u-
b a t e d   w i t h   t r y p s i n   o v e r n i g h t   ( C a t   #   T 7 5 7 5 ,   S i g m a   A l-
drich). Peptides generated from the trypsin digestion 
w e r e   t h e n   m i x e d   w i t h   a   m a t r i x  
(α-cyano-hydroxycinnamic  acid)  14,15  at  a  100–1000 
fold molar excess over the analyte 16.   T h i s   m i x t u r e   w a s  
t h e n   s p o t t e d   o n t o   a   t a r g e t   p l a t e   a n d   a l l o w e d   t o   e v a-
porate until crystals were formed. Spectra were col-
lected in reflectron positive ion mode over the mass 
range of 500 to 3000 Da. MASCOT software was used 
to  identify  the  proteins.  The  search  was  performed 
against  the  SwissProt  database  for  the  Homo  sapiens 
taxonomy. The following parameters were used: one 
missed cleavage, mass tolerance of 1.3 Da, oxidation 
of methionine (variable modification), and carbami-
domethylation (fixed modification).  
Densitometric analysis 
T h e   d e n s i t y   o f   t h e   s p o t s   w a s   m e a s u r e d   u s i n g  
ImageJ  Java-based  software  developed  at  National 
Institutes of Health (NIH) and available on the inter-
net  (http://rsb.info.nih.gov/nih-image/).  It  was 
based  on the a r e a   u n d e r   t h e   c u r v e   ( A U C )   f r o m   r e c-
tangular image captures. Fold change was calculated 
a s   t h e   r a t i o   o f   t h e   a r e a   o f   m a l i g n a n t   s t a t e   t o   t h a t   o f  
normal state. Fold regulation was then measured as 
the  following:  if  fold  change  >1,  it  remained  un-
c h a n g e d ;   i f   f o l d   c h a n g e   < 1 ,   t h e   n e g a t i v e   i n v e r s e   o f   i t  
was calculated to show downregulation.  
Results 
Differential protein expression in different pros-
tate tissue pathologies 
Densitometric analysis of proteins expressed in 
the s a m e   c e l l   t y p e   i n   n o r m a l ,   b e n i g n ,   c a n c e r o u s   a n d  
prostatitis tissues shows different levels of expression 
when  compared  to  normal  tissue  expression  levels 
(Table  1). Some proteins are upregulated, others are 
downregulated. Moreover, few proteins are found to 
be exclusively expressed either in the normal tissue or 
in the malignant one (Figure 2 and Figure 3). For ex-
a m p l e ,   f o u r   p r o t e i n s   a r e   upregulated  and  ten  are 
downregulated in endothelial cells of the hyperplastic 
tissue compared to the normal one. In prostate cancer, 
seven spots are overexpressed and four are downex-
pressed, while two spots were not detected.   I n   p r o s-
tatitis,  five  spots  are  upregulated,  seven  spots  are 
downregulated, and two proteins were not detected 
(Figure 3C).  
Identification of some putative protein bio-
markers 
MALDI-TOF analysis followed by Mascot search 
resulted in the identification of a subset of proteins in 
different cell types (Table 2). In leukocytes, we were 
ab l e   t o   i d e n t i f y   G T P -binding protein (GTPB1), junc-
tophilin, leucine-rich repeat serine/threonine-protein 
kinase  (LRRK2),  caspase1,  interleukin  18  receptor 
(IL18R), and Rab5 GDP/GTP exchange factor (Rabex5 
or  RAP1).  Proto-oncogene  Wnt-3,  uncharacterized 
serine/threonine-protein  kinase,  tyrosine-protein 
phosphatase  non-receptor  type  1(PTPN1  or  PTP1B) 
and  Arf-GAP  with  Rho-G A P   d o m a i n ,   A N K   r e p e a t  
and PH domain-containing protein 1 were found in 
endothelial  cells.  Integrin  alpha-6  and  poly 
ADP-ribose  polymerase  14  were  discovered  in  epi-
thelial cells and myofibroblasts. Cellular retinoic ac-
id-binding protein 2 (CRABP2) was identified in basal 
cells. Actin-related protein complex was found in all 
cell types. 
Table 1. Densitometric analysis of spots in Epithelial, Basal cells, Myofibroblasts, Leukocytes and Endothelial cells. The fold 
change is shown as compared to the normal. † NA: reflects no expression of the spot in the normal tissue sample. BPH, 
benign prostate hyperplasia. PCa, cancer of prostate. Titis, prostatitis. 
Spot#  Epithelial  Basal  Myofibroblast  Leukocytes  Endothelial 
  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis 
1  NA  NA  NA  2.2  6.85  7.1  1.92  1.79  -1.64  2.16  1.54  1.76  -1.18  1.30  1.01 
2  2.01  3.26  4.07  -1.2  2.63  1.76  1.37  1.09  -2.21  1.83  1.06  1.36  1.02  1.17  -1.04 
3  1.03  2.39  1.60  -1.24  2.04  1.79  -1.10  0  -1.40  1.44  1.47  1.94  -3.41  -1.26  1.03 
4  -5.65  1.16  0  -4.21  1.38  1.7  1.04  -1.06  1.85  1.85  2.21  0  -2.13  0  0 
5  NA  NA  NA  -1.25  1.44  1.33  1.08  0  1.29  1.28  1.75  1.73  -1.52  -1.85  -2.46 
6  1.91  1.83  1.67  -1.13  1.09  -1.12  -1.63  -2.09  -1.57  1.41  1.64  0  2.37  2.60  1.58 
7  -1.29  1.46  0  -2.26  1.07  -1.24  1.01  -1.19  -1.40  1.70  2.79  0  1.62  1.29  -1.55 
8  -2.51  1.08  0  -2  -1.3  -1.34  1.32  -1.16  1.01  0  2.35  0  -1.25  -1.50  -2.74 
9  1.62  1.65  -1.25  -1.15  1.69  2.24  1.03  -1.64  -1.31  0  NA  NA  1.62  -1.04  1.37 Journal of Cancer 2010, 1 
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Spot#  Epithelial  Basal  Myofibroblast  Leukocytes  Endothelial 
  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis  BPH  PCA  Titis 
10  1.50  2.27  1.26  -5.26  1.22  1.13  2.03  1.71  1.76  0  NA  NA  -1.32  -1.15  -1.38 
11  1.15  1.29  0  -1.78  1.94  1.4  1.72  1.29  1.48  1.08  2.24  1.56  -1.50  1.87  -1.27 
12  1.68  1.77  2.16  -1.52  0  2.15  -1.07  -1.35  -1.19  NA  NA  0  -1.44  1.12  -1.3 
13  1.51  1.88  1.88  -1.56  1.02  1  1.02  -2.25  -1.12  0  NA  NA  -1.13  1.12  1.05 
14  1.50  1.04  2.58  1.33  1.28  1.66  1.13  1.24  1.10  -2.65  2.05  -1.71  -1.40  0  0 
15  -1.24  1.17  -1.06  -1.16  -1.07  1.15  -1.07  1.38  -1.25  0  2.47  0       
16  1.18  1.63  1.68  0  0  0  1.70  1.02  1.05  0  1.15  -1.29       
17  1.46  1.96  2.08  -3.21  1  -1.44  -1.04  -1.01  1.04  0  -1.22  -2.17       
18  NA  NA  NA  -2.13  1  1.01        0  1.15  -1.29       
19  NA  NA  NA  -2.64  -1.97  -1.2        0  NA  0       
20  1.55  1.06  1.16  -1.43  -1.05  1.04                   
21  1.12  -1.04  -1.02                         
 
 
Figure 2. Proteins detected by two dimensional gel electrophoresis with SYPRO Ruby staining of epithelial cell fractions 
isolated from normal, benign (BPH), cancerous (PCa) and inflammatory (prostatitis) prostate tissues. A) Epithelial cells, B) 
Basal cells. The first dimension separation was performed on an 11cm linear IPG strip and the second dimension separation 
was accomplished on a 10% polyacrylamide gel. Annotated spots were quantified using imageJ, excised, trypsin digested, and 
analyzed by MALDI-TOF MS. Journal of Cancer 2010, 1 
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Figure 3. Proteins detected by two dimensional gel electrophoresis with SYPRO Ruby staining of stromal cell fractions 
isolated from normal, benign (BPH), cancerous (PCa) and inflammatory (prostatitis) prostate tissues under the same ex-
perimental conditions as described in figure 2. A) Myofibroblasts, B) Leukocytes, C) Endothelial cells. 
Table 2. Proteins identified using MALDI-TOF MS and their respective densities in benign (BPH), cancerous (PCa) and 
inflammatory (Titis) prostate tissues. 
Spot# Cell type  Protein  Score  Mw  PI  BPH  PCa  Titis 
14  Leukocytes  Caspase-1  69  45814  5.63  -2.65  2.05  -1.71 
8  Leukocytes  GTP-binding protein 1 (GTPB1)  62  73035  8.6  0  2.35  0 
19  Leukocytes  Junctophilin-1  76  72098  9.37  0  NA  0 
12  Leukocytes  leucine-rich repeat protein kinase (LRRK2)  61  289568  6.35  NA  NA  0 
4  Leukocytes  Interleukin-18 receptor 1(IL18R1)  63  63119  8.06  1.85  2.21  0 
3  Leukocytes  Rab5 GDP/GTP exchange factor  59  80575  6.42  1.44  1.47  1.94 
2  Endothelial  Proto-oncogene Wnt-3  66  40988  7.46  1.02  1.17  -1.04 
3  Endothelial  Uncharacterized serine/threonine-protein kinase  61  31480  9.12  -3.41  -1.26  1.03 
14  Endothelial  Tyrosine-protein phosphatase non-receptor type 1 
(PTPN1) 
59  50505  5.88  -1.04  0  0 
1  Endothelial  Arf-GAP with Rho-GAP domain, ANK repeat and PH 
domain-containing protein 1(ARAP1) 
59  163743  5.86  -1.18  1.3  1.01 
15  Basal  Actin-related protein 2/3 complex subunit 3  62  20761  8.78  -1.16  -1.07  1.15 
18  Basal  Cellular retinoic acid-binding protein 2 (CRABP2)  59  15854  5.42  -2.13  1  1.01 
13  Epithelial   Uncharacterized protein  58  108689  6.68  1.51  1.88  1.88 
3  Epithelial   Integrin alpha-6  60  127751  6.39  1.03  2.39  1.6 
2  Epithelial   Poly ADP-ribose polymerase 14 (PARP14)  59  195627  8.21  2.01  3.26  4.07 
13  Myofibroblasts  Uncharacterized protein  58  108689  6.68  1.02  -2.25  -1.12 
3  Myofibroblasts  Integrin alpha-6  60  127751  6.39  -1.1  0  -1.4 
2  Myofibroblasts  Poly ADP-ribose polymerase 14 (PARP14)  59  195627  8.21  1.37  1.09  -2.21 
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Discussion 
The  epithelium  of  normal  and  preneoplastic 
prostate  gland  is  underpinned  by  a  basal cell  layer 
and a basement membrane w h i c h   s e p a r a t e   i t   f r o m   t h e  
stroma and act as messengers mediating its commu-
nication  with  the  surrounding  microenvironment  3. 
To become invasive, carcinoma cells must first pass 
through the basal cell layer and the underlying base-
ment  membrane.  A  common  diagnostic  feature  of 
prostate cancer progression from in situ to invasive 
tumor is the gradual disappearance of fully differen-
tiated basal cell layer 8. This implies that abrogation of 
the basal cell layer is an absolute prerequisite for tu-
mor invasion. Whilst most of the  concepts  regarding 
disruption of the basal cell layer and the underlying 
basement  membrane  defined  a  prominent  role  of 
proteolytic  enzymes  17,18, clinical trials using protei-
nase inhibitors have been disappointing 3,19 and only 
10-3 0 %   o f   P I N   l e s i o n s   e x p r e s s i n g   h i g h   l e v e l s   o f   p r o-
teinases become invasive 20,21. This suggests an alter-
native pathway of prostate cancer  progression  and 
i n v a s i o n .   R e c e n t l y ,   n u m e r o u s   s t u d i e s   s u p p o r t   t h e  
hypothesis  that  tumor  microenvironment  plays  im-
portant roles in cancer initiation, growth, progression, 
invasion,  and  metastasis.  T h e   s t r o m a   i s   n o   l o n g e r  
perceived  as  a  reactive  responder  to  the  neoplastic 
process, but rather as an interactive component that 
actively affects the fate of the adjacent epithelium. 
 S o   f a r ,   i t   i s   u n k n o w n   w h a t   m e c h a n i s m s   l e a d   t o  
focal basal cell layer disruptions and its contribution 
to  tumor  progression.  To  identify  the  intrinsic  me-
c h a n i s m   o f   t u m o r   i n i t i a t i o n   a n d   p r o g r e s s i o n ,   M a n   et 
al. suggested a potential role of autoimmune reactions 
in malignant transformation. Focally disrupted basal 
cell  layers  were  correlated  with  higher  leukocytes 
influx. They exhibited lower proliferation rate, lower 
tumor  suppressor  genes  expression  and  higher 
apoptosis.  The  tumor  epithelial  cells  overlying  dis-
rupted basal cells also showed substantial differences 
f r o m   o t h e r   e p i t h e l i a l   c e l l s   i n   t h e   d u c t s .   T h e y   d i s p l a y e d  
a higher proliferation rate and a higher expression of 
invasion and cell cycle related genes 3,8. Whether this 
hypothesis reflects the sole trigger of tumor initiation 
is vague and requires further investigation.  
Recently, Polyak et al. proposed two alternative 
models of in situ to invasive carcinoma transition in 
mammary gland 22. The “Escape” model suggests that 
a genetically distinct tumor epithelial cell clone will 
disrupt the myoepithelial cell layer and the underly-
ing basement membrane, escape from the duct and 
m i g r a t e   i n t o   t h e   s t r o m a .   I n   t h e   “ R e l e a s e ”   m o d e l ,  
myoepithelial cells will cooperate with leukocytes and 
myofib r o b l a s t s   t o   b r e a k   d o w n   t h e   d u c t s   a n d   r e l e a s e  
tumor epithelial cells. Polyak purported that the two 
m o d e l s   m a y   n o t   b e   m u t u a l l y   e x c l u s i v e   a n d   m y o e p i-
thalial cells together with infiltrating leukocytes and 
myofibroblasts may affect the clonal evolution of tu-
mor  epithelial  cells.  Moreover,  recent  genomic  cha-
racterization  of  tumor  microenvironment  was  done 
b y   t h e   p u r i f i c a t i o n   o f   a l l   m a j o r   c e l l   t y p e s   f r o m   n o r m a l  
breast  tissue,  ductal  carcinoma  in  situ  (DCIS),  and 
invasive carcinomas 23. They found genetic changes in 
a l l   c e l l   t y p e s   o f   t h e   m a m m a r y   g l a nd suggesting that 
tumor progression results from reciprocal interactions 
between epithelial and stromal cells challenging the 
old paradigm of epithelial cell-driven tumorigenesis. 
Due to similarities between mammary and prostate 
glands,  the  potential  involvement  of  all  stromal  cell 
types in initiation of invasion in prostate cancer needs 
to  be  addressed.  To  elucidate  this  mechanism,  epi-
thelial and stromal cells were isolated from different 
prostate tissue pathologies. This study a i m s   t o   r e c o g-
nize specific protein signatures that may govern the 
b r e a k d o w n   o f   b a s a l   c e l l   l a y e r ,   t h e r e b y   leading to the 
initiation of tumor invasion. 
2-DE  of proteins  extracted  from  epithelial  cells 
(Figure 2) a n d   s t r o m a l   c e l l s   ( F i g u r e   3 )   isolated from 
normal,  benign,  cancerous,  and  inflammatory  pros-
tate  tissues  shows  differential  protein  signatures 
w i t h i n   t h e   s a m e   c e l l   t y p e   i n   d i f f e r e n t   p r o s t a t e   t i s s u e  
pathologies that support the differential gene expres-
sion pattern found in epithelial cells and stromal cells 
in normal versus cancerous prostate  9,10. Densitome-
tric analysis of the spots reveals distinct expression 
pattern among the proteins in benign, cancerous and 
prostatitis tissues as compared to normal tissue. Some 
p r o t e i n s   a r e   o n l y   e x p r e s s e d   i n   n o r m a l   t i s s u e s ,   o t h e r s  
s t a r t   t o   a p p e a r   i n   B P H   a n d   i n c r e a s e   i n   p r o s t a t e   c a n c e r  
suggesting their involvement in tumor initiation and 
progression (Table 1). 
We were able to identify some proteins in leu-
kocytes, endothelial cells, basal cells, epithelial cells, 
and myofibroblasts (Table 2). In leukocytes, caspase-1 
i s   f o u n d   i n   s p o t  # 14 and appears to be highly ex-
p r e s s e d   i n   p r o s t a t e   c a n c e r .   I t   i s   a   p r o t e o l y t i c   e n z y m e  
that  cleaves  some  components  of  the  inflammatory 
response  such  as  interleukin-1β  and  interleukin-18 
into  active  peptides  24.  Caspase-1,  also  known  as 
IL-1β-converting enzyme, is synthesized as a zymo-
gen which is activated by cleavage and dimerization 
o f   i t s   1 0   K D a   a n d   2 0   K D a   s u b u n i t s .   I t   h a s   b e e n   s h o w n  
to be involved in the formation of inflammasome and 
the activation of inflammatory response and apopto-
sis 25. Caspase-1 expression level was investigated in 
epithelial cells of hyperplastic  26 and malignant pros-
tate  27. The expression of caspase-1 was dramatically 
d i m i n i s h e d   i n   t h e   h y p e r p l a s t i c   t i s s u e   a s   c o m p a r e d   t o  Journal of Cancer 2010, 1 
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the  normal  control  26. Moreover, its expression was 
completely  lost  in  prostate  cancer  specimens  27. 
However, caspase-1   e x p r e s s i o n   w a s   n o t   r e p o r t e d   i n  
stromal cells of prostate cancer tissues. 
Interleukin-18  receptor  1 (IL18R1),  identified  in 
leukocytes (spot # 4), is a receptor for the proinflam-
matory cytokine, IL18, that determines the develop-
ment and function of T   a n d   N K   c e l l s   28,29 and is acti-
vated by caspase-1  30.  Its  expression  increases  from 
n o r m a l   t o   b e n i g n   t o   c a n c e r o u s   p r o s t a t e   t i s s u e s .   I t   h a s  
been  reported  that  IL18R  is  expressed  in  spleen, 
thymus,  leukocytes,  liver,  lung,  heart,  prostate, and 
placenta  31.  Recently,  a  study  showed  that  IL18  is 
produced by prostate cancer cell lines and its receptor 
IL-1 8 R 1   w a s   f o u n d   t o   b e   e x p r e s s e d   i n   t h e  poorly dif-
ferentiated  prostate  cancer  cell  lines,  PC-3  and 
DU-145,  but  is  absent  in  the  well  differentiated 
LNCaP  cells  suggesting  a  correlation  with  tumor 
progression 32.  
Rab5 GDP/GTP exchange factor or Rabex-5, also 
identified  in  leukocytes,  is  involved  in  membrane 
trafficking  33.   I t   d i s p l a y s   G D P / G T P   e x c h a n g e   a c t i v i t y 
o n   R a b 5 ,   a   m e m b e r   o f   R a s   s u p e r f a m i l y   o f   G   p r o t e i n s ,  
by complexing with Rabaptin-5 which is a direct ef-
fector of Rab5 34.   R a b e x -5-Rabaptin-5   c o m p l e x   h e l p s   t o  
translocate  the  Rab5  GTPase  to  the  membrane  en-
hancing membrane docking and fusion 33. 
The  proto-oncogene  Wnt-3  is  identified  in  en-
dothelial cells. It is a member of Wnt family of pro-
teins which are involved in oncogenesis and various 
developmental processes including cell proliferation, 
differentiation, and cell fate 35. Aberrant Wnt signal-
ing  through  β-catenin  is  known  to  affect  prostate 
cancer  progression  and  bone  metastasis  36.  PTPN1 
(protein tyrosine phosphatase non-receptor type 1, or 
PTP1B) is expressed in endothelial cells of normal and 
benign  prostate.  Contradictory  data  suggests  that 
PTP1B has both inhibitory and stimulatory effects on 
t u m o r s   b a s e d   o n   t h e   a s s o c i a t e d   p r o t e i n s   a n d   t h e   c e l-
lular  context  37. As a tumor suppressor, PTP1B was 
found to decrease tumorigenecity of v-src-expressing 
cells  38 a n d   n e u   T M -transformed cells 39.   O n   t h e   c o n-
t r a r y ,   P T P 1 B   w a s   r e p o r t e d   t o   b e   a n   o n c o g e n e   a s s o-
ciated  with  breast  tumorigenesis  40  and  capable  of 
activating src oncogene 41. Whether PTP1B is a tumor 
s u p p r e s s o r   o r   t u m o r   p r o m o t e r   o r   b o t h   i s   s t i l l   d e b a t a-
ble and requires further investigation. In the prostate, 
PTP1B has been linked to neuroendocrine differentia-
tion which is associated with androgen independent 
tumors suggesting an implication in prostate cancer 
progression 42. ARAP1 contains Arf-GAP, RHO-GAP, 
Ankyrin repeat, Ras-associating and five PH domains. 
A s s o c i a t e d   w i t h   t h e   G o l g i ,   A R A P 1   c a n   m e d i a t e   c e l l  
rounding, loss of stress fibers, changes in golgi struc-
ture and filopodia 43. It regulates endocytic trafficking 
of the epidermal growth factor receptor (EGFR) 44 and 
DR4, a receptor protein involved in apoptosis 45.  
Cellular  retinoic  acid-binding  protein  2 
( C R A B P 2 ) ,   i d e n t i f i e d   i n   n o r m a l   a n d   b enign prostate 
tissues of basal cells, is an intracellular lipid binding 
protein that associates with retinoic acid and mediates 
its actions in cell growth, differentiation, apoptosis, 
and  anti-tumorigenesis  46.   C R A B P 2   i s   f o u n d   t o   b e  
down regulated in prostate cancer and thus, can be a 
novel therapeutic marker for prostate cancer 47.  
Integrin α-6 is a member of the integrins which 
are cell surface receptors for extracellular matrix pro-
teins involved in cell migration, differentiation, cell 
survival, and tissue organization. The laminin binding 
integrin α-6 expression increases in the epithelial cells 
a s   n o r m a l   t i s s u e   p r o g r e s s e s   i n t o   b e n i g n   a n d   c a n c e r-
ous.  However,  its   e x p r e s s i o n   r e m a i n e d   a l m o s t   t h e  
same  in  the  myofibroblasts  of  hyperplastic  prostate 
but diminished in the myofibroblasts of tumorigenic 
prostate.  Several  studies  have  reported  higher  ex-
pression  of  α-6  integrin  in  invasive  and  migrating 
human prostate cancers as opposed to other integrins 
48. Recently, a novel variant of α-6 integrin called α-6p 
generated by urokinase plasminogen activator (uPA) 
mediated  cleavage  of  laminin  binding  domain  was 
reported to increase cellular migration and invasion 
on laminin substrates 49,50,   a n d   t o   e n h a n c e   t u m o r   c e l l s  
tropism  to  the  laminin  rich  bone  microenvironment 
51,52.  Moreover,  inhibition  of  uPA-dependent  α-6  in-
t e g r i n   c l e a v a g e   d e l a y e d   h u m a n   p r o s t a t e   c a n c e r   m e-
tastasis  52.   P A R P 1 4   i s   a   p o l y   A D P -ribose polymerase 
which catalyzes the transfer of ADP-ribose from NAD 
to target proteins i n v o l v e d   i n   D N A   d a m a g e   a n d   r e-
pair, apoptosis, and transcription and it was reported 
to signal B-cell survival 53. 
Conclusion 
The  concept  of  microenvironmental  effects  on 
tumor invasion constitutes a paradigm-shift from the 
“protease-centered”  hypothesis  that  focuses  on 
basement  membrane  degradation  and  the  develop-
m e n t   o f   p r o t e a s e   i n h i b i t o r s   t o   p r e v e n t   t u m o r   i n v a s i o n  
and  metastasis.  The role of the stroma in malignant 
transformation is growing steadily which focuses on 
reciprocal  interactions  between  the  epithelium  and 
the surrounding microenvironment. To elucidate this 
role  in  prostate  cancer,  we  have  isolated  epithelial 
cells, basal cells, endothelial cells, myofibroblasts, and 
leukocytes, from human normal, prostatitis, BPH, and 
prostate cancer tissues to study their protein expres-
sion.   T h e   p r o t e i n   p r o f i l e s   o f   t h e   d i f f e r e n t   c e l l s   s h o w  
differential  protein  signatures  for  each  pathology. 
F u r t h e r m o r e ,   w e   w e r e   a b l e   t o   i d e n t i f y   s o m e   novel Journal of Cancer 2010, 1 
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molecules that may be responsible for basal cell layer 
disruption and disappearance during the progression 
of in  situ t u m o r s   t o   i n v a s i v e   c a n c e r s .  Further valida-
tion of these proteins’ identity may lead to verification 
of some early invasion-promoting protein biomarkers 
that may be targeted to prevent invasion.  
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